Trial Profile
Phase II trial of SYN 120 in patients with Alzheimer's disease
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 12 Mar 2014
Price :
$35
*
At a glance
- Drugs Landipirdine (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 28 Feb 2014 Preparations for this study have started, with the study expected to begin recruitment by the end of 2014, according to a Biotie media release.
- 02 Mar 2012 New trial record